More search options
Basket icon
No items
Basket icon

Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Compact case
Case
-
Reference no. CG2B
Subject category: Ethics and Social Responsibility
Authors: Constance E Bagley (Stanford Graduate School of Business, Stanford University); Rakesh R Khanna (Stanford University)
Published by: Stanford Business School
Originally published in: 1995
Version: June 1995
Length: 4 pages
Data source: Published sources
Topics: Corporate governance; Board of directors; Corporate responsibility; Non-profit organizations; Acquisitions; Pharmaceuticals
Share a link: https://casecent.re/p/102116
| No reviews for this item
This product has not been used yet
View our pricing guide or login to see prices.

Abstract

Describes the sale of Wellcome plc to GLAXO plc in 1995. Explains why the Wellcome Trust, the Largest stockholder of Wellcome plc, decided to accept a tender offer by GLAXO plc that was opposed by the board of directors Wellcome plc. Addresses the consequences of the Wellcome Trust's decision.
Location:
UK
Other setting(s):
1995
Sorry, this product has no related items.

About

Abstract

Describes the sale of Wellcome plc to GLAXO plc in 1995. Explains why the Wellcome Trust, the Largest stockholder of Wellcome plc, decided to accept a tender offer by GLAXO plc that was opposed by the board of directors Wellcome plc. Addresses the consequences of the Wellcome Trust's decision.

Settings

Location:
UK
Other setting(s):
1995

Related

Sorry, this product has no related items.